206 related articles for article (PubMed ID: 10640777)
1. Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer.
Kim KN; Watanabe S; Ma Y; Thornton S; Giannini EH; Hirsch R
J Immunol; 2000 Feb; 164(3):1576-81. PubMed ID: 10640777
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer.
Ma Y; Thornton S; Duwel LE; Boivin GP; Giannini EH; Leiden JM; Bluestone JA; Hirsch R
J Immunol; 1998 Aug; 161(3):1516-24. PubMed ID: 9686619
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis.
Apparailly F; Verwaerde C; Jacquet C; Auriault C; Sany J; Jorgensen C
J Immunol; 1998 Jun; 160(11):5213-20. PubMed ID: 9605116
[TBL] [Abstract][Full Text] [Related]
4. Murine IL-10 gene transfer inhibits established collagen-induced arthritis and reduces adenovirus-mediated inflammatory responses in mouse liver.
Quattrocchi E; Dallman MJ; Dhillon AP; Quaglia A; Bagnato G; Feldmann M
J Immunol; 2001 May; 166(10):5970-8. PubMed ID: 11342612
[TBL] [Abstract][Full Text] [Related]
5. Electro-gene therapy of collagen-induced arthritis by using an expression plasmid for the soluble p75 tumor necrosis factor receptor-Fc fusion protein.
Kim JM; Ho SH; Hahn W; Jeong JG; Park EJ; Lee HJ; Yu SS; Lee CS; Lee YW; Kim S
Gene Ther; 2003 Aug; 10(15):1216-24. PubMed ID: 12858186
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis.
Quattrocchi E; Walmsley M; Browne K; Williams RO; Marinova-Mutafchieva L; Buurman W; Butler DM; Feldmann M
J Immunol; 1999 Jul; 163(2):1000-9. PubMed ID: 10395698
[TBL] [Abstract][Full Text] [Related]
7. Depletion of collagen II-reactive T cells and blocking of B cell activation prevents collagen II-induced arthritis in DBA/1j mice.
Zhang HG; Yang P; Xie J; Liu Z; Liu D; Xiu L; Zhou T; Wang Y; Hsu HC; Mountz JD
J Immunol; 2002 Apr; 168(8):4164-72. PubMed ID: 11937577
[TBL] [Abstract][Full Text] [Related]
8. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
9. Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees.
Lechman ER; Jaffurs D; Ghivizzani SC; Gambotto A; Kovesdi I; Mi Z; Evans CH; Robbins PD
J Immunol; 1999 Aug; 163(4):2202-8. PubMed ID: 10438962
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws.
Whalen JD; Lechman EL; Carlos CA; Weiss K; Kovesdi I; Glorioso JC; Robbins PD; Evans CH
J Immunol; 1999 Mar; 162(6):3625-32. PubMed ID: 10092823
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein.
Banda NK; Vondracek A; Kraus D; Dinarello CA; Kim SH; Bendele A; Senaldi G; Arend WP
J Immunol; 2003 Feb; 170(4):2100-5. PubMed ID: 12574381
[TBL] [Abstract][Full Text] [Related]
12. Prevention of collagen-induced arthritis by gene delivery of soluble p75 tumour necrosis factor receptor.
Mageed RA; Adams G; Woodrow D; Podhajcer OL; Chernajovsky Y
Gene Ther; 1998 Dec; 5(12):1584-92. PubMed ID: 10023437
[TBL] [Abstract][Full Text] [Related]
13. Redirection of T cell effector function in vivo and enhanced collagen-induced arthritis mediated by an IL-2R beta/IL-4R alpha chimeric cytokine receptor transgene.
Chen Y; Rosloniec E; Goral MI; Boothby M; Chen J
J Immunol; 2001 Mar; 166(6):4163-9. PubMed ID: 11238667
[TBL] [Abstract][Full Text] [Related]
14. Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4.
Kim SH; Kim S; Evans CH; Ghivizzani SC; Oligino T; Robbins PD
J Immunol; 2001 Mar; 166(5):3499-505. PubMed ID: 11207309
[TBL] [Abstract][Full Text] [Related]
15. Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis.
Ferrari-Lacraz S; Zanelli E; Neuberg M; Donskoy E; Kim YS; Zheng XX; Hancock WW; Maslinski W; Li XC; Strom TB; Moll T
J Immunol; 2004 Nov; 173(9):5818-26. PubMed ID: 15494535
[TBL] [Abstract][Full Text] [Related]
16. Prevention of collagen-induced arthritis in mice transgenic for the complement inhibitor complement receptor 1-related gene/protein y.
Banda NK; Kraus DM; Muggli M; Bendele A; Holers VM; Arend WP
J Immunol; 2003 Aug; 171(4):2109-15. PubMed ID: 12902517
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
18. Collagen-induced arthritis in DBA/1 mice: cytokine gene activation following immunization with type II collagen.
Stasiuk LM; Abehsira-Amar O; Fournier C
Cell Immunol; 1996 Nov; 173(2):269-75. PubMed ID: 8912886
[TBL] [Abstract][Full Text] [Related]
19. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis.
Lubberts E; Joosten LA; Oppers B; van den Bersselaar L; Coenen-de Roo CJ; Kolls JK; Schwarzenberger P; van de Loo FA; van den Berg WB
J Immunol; 2001 Jul; 167(2):1004-13. PubMed ID: 11441109
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
Lubberts E; Joosten LA; van Den Bersselaar L; Helsen MM; Bakker AC; van Meurs JB; Graham FL; Richards CD; van Den Berg WB
J Immunol; 1999 Oct; 163(8):4546-56. PubMed ID: 10510398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
